Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2001
02/28/2001CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists
02/28/2001CN1285350A 1-cyclenes tetraazolelinketone and the like
02/28/2001CN1062557C Recovery of 2,2'-combined dipyridine of atom transferred free radical polymeris
02/27/2001US6194581 Substituted pyridines useful as modulators of acetylcholine receptors
02/27/2001US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
02/27/2001US6194440 Small molecule carbamate or urea hair growth compositions and uses
02/27/2001US6194439 Tricyclic polyhydroxylic tyrosine kinase inhibitors
02/27/2001US6194438 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives
02/27/2001US6194437 Non-peptide bombesin receptor antagonists
02/27/2001US6194434 Cycloalkylaminomethylpyrrolidine derivatives
02/27/2001US6194428 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
02/27/2001US6194427 Brain disorders; psychological disorders; sleep disorders; anticonvulsants
02/27/2001US6194425 Viricides, antitumor agents
02/27/2001US6194418 Bactericides, pesticides
02/27/2001US6194416 Central nervous system disorders; alzheimer's disease
02/27/2001US6194413 Hemoregulatory compounds
02/27/2001US6194409 Heterocyclic derivatives and their use as antithrombotic agents
02/27/2001US6194406 Histamine receptor antagonists; tachykinin receptor antagonists; asthma; bronchitis; inflammatory bowel diseases, including crohn's disease and ulcerative colitis; seasonal rhinitis; sinusitis; antiallergens; emetic agents
02/27/2001US6194403 Alpha, omega-bis-(6-chloro)tacrinyl-alkane, for example; a more selective acetylcholinesterase inhibitor; potentiation; side effects reduction
02/27/2001US6194396 Benzimidazole compounds as bradykinin antagonists
02/27/2001US6194132 Photographic element, compound, and process
02/27/2001CA2124206C Indole derivatives
02/27/2001CA2111204C Piperidine derivatives having anxiolytic effect
02/22/2001WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001WO2001012622A1 Piperidine and pyrrolidine derivatives displaying neuronal activity
02/22/2001WO2001012612A1 Benzoic acid derivatives for the treatment of diabetes mellitus
02/22/2001WO2001012609A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions
02/22/2001WO2001012607A2 Pharmaceutical compositions comprising 4-quinolones for treating cancers
02/22/2001WO2001012604A1 Fungicides
02/22/2001WO2001012601A1 Novel anilide derivatives or salts thereof and drugs containing the same
02/22/2001WO2001012600A1 INHIBITORS OF FACTOR Xa
02/22/2001WO2001012584A2 Pharmaceutical compounds
02/22/2001WO2001012189A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
02/22/2001WO2001012187A2 Benzoic acid derivatives and their use as ppar receptor agonists
02/22/2001WO2001012186A1 Cell adhesion inhibitors
02/22/2001WO2001011966A1 Fungicides
02/22/2001WO2001011965A1 Fungicides
02/22/2001WO2000078724A3 Imidazolinderivatives their preparation and their pharmaceutical use
02/22/2001WO2000055126A3 N-cyanomethylamides as protease inhibitors
02/22/2001WO2000032588A3 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001DE19939756A1 New 1-(1-ethyl-piperidin-4-yl)-1-(phenyl or heterocyclyl)-alkanol derivatives, are 5-HT(2A) receptor antagonists useful e.g. for treating schizophrenia, depression, memory disorders or eating disorders
02/22/2001DE19939463A1 Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides
02/22/2001CA2698353A1 Pharmaceutical compounds
02/22/2001CA2383268A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions
02/22/2001CA2381975A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/22/2001CA2381968A1 Pharmaceutical compositions comprising 4-quinolones for treating cancers
02/22/2001CA2381409A1 Nitric ester derivatives
02/22/2001CA2381090A1 Benzoic acid derivatives for the treatment of diabetes mellitus
02/22/2001CA2380817A1 Cell adhesion inhibitors
02/22/2001CA2380775A1 Benzoic acid derivatives and their use as ppar receptor agonists
02/21/2001EP1077227A1 Stabilizer mixtures
02/21/2001EP1077213A2 Inhibition of serotonin reuptake
02/21/2001EP1076658A1 Serotonergic agents
02/21/2001EP1076656A2 N-heteroaryl-substituted pyridine derivatives and their use as herbicides
02/21/2001EP1076655A1 N-pyridonyl herbicides
02/21/2001EP1076648A1 Method for the catalytic production of substituted dipyridyl derivatives
02/21/2001EP1076560A1 Inhibition of protein kinases with piridinylimidazoles
02/21/2001EP1076558A1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
02/21/2001CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis
02/21/2001CN1284955A 整联蛋白受体拮抗剂 Integrin receptor antagonists
02/21/2001CN1284947A Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
02/21/2001CN1284946A Substituted isoquinoline derivatives and their use as anticonvulsants
02/21/2001CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use
02/21/2001CN1284944A Integrin receptor antagonists
02/21/2001CN1284875A Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
02/21/2001CN1284868A Oral pharmaceutical pulsed release dosage form
02/21/2001CN1284866A Oral pharmaceutical extended release dosage form
02/21/2001CN1062265C Method for producing triazine derivatives
02/20/2001US6191282 Derivatives of 5-membered nitrogen containing heterocyclic ring is used as anticarcinogenic agent and anticoagulant
02/20/2001US6191161 Prolylendopeptidase inhibitors
02/20/2001US6191160 Spiro-indolines as Y5 receptor antagonists
02/20/2001US6191159 Anticoagulants
02/20/2001US6191149 Heterocyclic derivative and medicine
02/20/2001US6191148 Omerazole process and compositions thereof
02/20/2001US6191147 Pyrazole compounds and uses thereof
02/20/2001US6191145 Anticoagulants; antiinflammatory agents
02/20/2001US6191143 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
02/20/2001US6191142 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
02/20/2001US6191135 Respiratory system disorders, antiinflammatory agents; analgesics
02/20/2001US6191125 Small molecule pipecolic acid derivative hair growth compositions and uses
02/20/2001US6190850 Photographic element, compound, and process
02/15/2001WO2001010867A1 Vitronectin receptor antagonists useful for the treatment of strokes
02/15/2001WO2001010860A2 Quinazolinone and azaquinazolinone derivatives
02/15/2001WO2001010859A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
02/15/2001WO2001010847A2 Novel integrin receptor antagonists
02/15/2001WO2001010843A1 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient
02/15/2001WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001WO2001010834A2 Antibacterial agents
02/15/2001WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
02/15/2001WO2001010381A2 Methods for treating or preventing pain and anxiety
02/15/2001WO2001010380A2 Benzanilides as potassium channel openers
02/15/2001WO2000059497A8 Pyrrolidine modulators of chemokine receptor activity
02/15/2001DE19937496A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents, e.g. for treating viral infections, tumors, inflammation or autoimmune disease
02/15/2001DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin
02/15/2001CA2381621A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001CA2379977A1 Novel integrin receptor antagonists
02/15/2001CA2378241A1 Benzanilides as potassium channel openers
02/14/2001EP1076057A1 Febrifugine and isofebrifugine and processes for the preparation of both